This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Set to Soar on Bullish Earnings

Stocks in this article: LLTCFASTAMAGINTCPLXS

Amag Pharmaceuticals

Another potential earnings short-squeeze candidate is biopharmaceutical player Amag Pharmaceuticals (AMAG) which is set to release numbers on Wednesday before the market open. Wall Street analysts, on average, expect Amag Pharmaceuticals to report revenue of $21.12 million on a loss of 7 cents per share.

>>5 Big Trades to Take This Year

The current short interest as a percentage of the float for Amag Pharmaceuticals stands at 3.1%. That means that out of the 15.97 million shares in the tradable float, around 673,000 shares are sold short by the bears. The bears have also been increasing their bets from the last reporting period by 9.3%, or by about 57,000 shares. If the bears get caught pressing their bets into a strong quarter, then shares of AMAG could easily jump sharply higher post-earnings as the bears rush to cover some of their bets.

From a technical perspective, AMAG is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been downtrending for the last two months, with shares moving lower from its high of $28.42 to its recent low of $20.03 a share. During that downtrend, shares of AMAG have been making mostly lower highs and lower lows, which is bearish technical price action. That said, shares of AMAG have now started to rebound higher off that $20.03 low and it's quickly moving within range of triggering a near-term breakout trade post-earnings.

If you're bullish on AMAG, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at its 200-day moving average of $23.05 to its 50-day moving average of $24.13 a share and then once it clears more near-term overhead resistance levels at $24.93 to $25.98 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 166,206 shares. If that breakout hits, then AMAG will set up to re-test or possibly take out its next major overhead resistance levels at its 52-week high of $28.42 to $32 a share.

I would avoid AMAG or look for short-biased trades if after earnings it fails to trigger that breakout and then drops back below some key near-term support levels at $20.03 to $18.94 a share with high volume. If we get that move, then AMAG will set up to re-test or possibly take out its next major support level at its 52-week low of $15 a share.

4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,390.52 +195.10 1.13%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,630.7410 +64.6030 1.41%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs